reversible LSD1 inhibitors (The first people Hospital of Taizhou/Nanjing Sports Institute)

N/A

Report date: 2025/03/19 11:44:31
NME

Base Information

Drug Namereversible LSD1 inhibitors (The first people Hospital of Taizhou/Nanjing Sports Institute)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionLysine-specific histone demethylase 1 inhibitors
TargetsLysine-specific histone demethylase 1
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesThe First People Hospital Of Taizhou
China Registration ClassN/A

Develop Information

Active CompaniesThe First People Hospital Of TaizhouNanjing Institute Of Physical Education
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A